Obecność farmaceutyków w wodach powierzchniowych i przeznaczonych do spożycia

• Autorzy: Szymonik A. , Lach J.

Identyfikatory

DOI

10.2429/proc.2013.7(2)096

Warianty tytułu

EN

Pharmaceuticals in surface and drinking water

• Konferencja: ECOpole’13 Conference (23-26.10.2013, Jarnoltowek, Poland)
• Języki publikacji: PL

Abstrakty

PL

W pracy przedstawiono stężenia wybranych farmaceutyków w ściekach nieoczyszczonych i po oczyszczeniu, wodach powierzchniowych i wodach przeznaczonych do spożycia w Polsce oraz na świecie. Opisano również wpływ farmaceutyków na człowieka i organizmy wodne. Najczęściej identyfikowanymi lekami w ściekach są: beta-blokery (atenolol, propanolol, metoprolol), niesteroidowe leki przeciwzapalne (diklofenak, naproksen, ketoprofen), hormony płciowe (naturalne: estron, 17 b-estradiol, estriol i syntetyczne: etinyloestradiol), karbamazepina - lek przeciwpadaczkowy, regulatory gospodarki lipidowej - fibraty (kwas klofibrowy, gemfibrozil, bezafibrat). Dane leki są trudno usuwalne w nawet rozbudowanych procesach oczyszczania ścieków. Karbamazepina ulega eliminacji w 10%, diklofenak od 21 do 40%, naproksen w 50-80%, metoprolol (beta-bloker) do 25%, a propanolol (najbardziej lipofilowy beta-bloker) jest prawie nieusuwalny. Obecność leków w wodach powierzchniowych jest problemem globalnym.

EN

The article presents the analysis of the concentrations of selected pharmaceuticals in non-treated and treated wastewater, surface water and drinking water in Poland and around the world. Also, the effects of pharmaceuticals on human beings and aqueous organisms were discussed. Among pharmaceuticals the most frequently identified in wastewater are: beta-blockers (ie atenolol, propanolol, metaprolol), non steroidal anti inflammatory drugs (ie diclofenac, naproxen, ketoprofen), estogens (natural: estrone, 17 b-estradiol, estriol and synthetic: ethinylestradiol), carbamazepine - an anticonvulsant drug, and lipid regulators - fibrates (ie clofibric acid, gemfibrozil, bezafibrate). Some of these pharmaceuticals are difficult to remove even through advanced processes of wastewater treatment. Carbamazepine can be removed by 10%, diclofenac can be removed by 21 up to 40%, naproxen can be removed by 50-80%, metoprolol (that belongs to the group of beta-blockers) can be removed by 25%, and propanolol (the most lipophilic beta-blocker) is almost non removable. The presence of pharmaceuticals in surface water is now considered a global issue.

Słowa kluczowe

PL

farmaceutyki; wody powierzchniowe; woda przeznaczona do spożycia; toksyczność

EN

pharmaceuticals; surface water; drinking water; toxicity

• Wydawca: Towarzystwo Chemii i Inżynierii Ekologicznej
• Czasopismo: Proceedings of ECOpole
• Rocznik: 2013
• Tom: Vol. 7, No. 2
• Strony: 735--743
• Opis fizyczny: Bibliogr. 39 poz., tab.

Twórcy

autor

Szymonik A.

• Instytut Inżynierii Środowiska, Politechnika Częstochowska, ul. Brzeźnicka 60a, 42-200 Częstochowa, tel. [phone]

autor

Lach J.

• Instytut Inżynierii Środowiska, Politechnika Częstochowska, ul. Brzeźnicka 60a, 42-200 Częstochowa, tel. [phone]

Bibliografia

• [1] Vazquez-Roig P, Blasco C, Picó Y. Advances in the analysis of legal and illegal drugs in the aquatic environment. Trends in Analytical Chem. 2013;50: 65-77. DOI: 10.1016/j.trac.2013.04.008.
• [2] Sukul P, Spiteller M. Fluoroquinolone antibiotics in the environment. Rev Environ Contam Toxicol. 2007;191:131-162.
• [3] Scheurer M, Ramil M, Metcalfe CD, Groh S, Ternes TA. The challenge of analyzing beta-blocker drugs in sludge and wastewater. Anal Bioanal Chem. 2010;396:845-856. DOI: 10.1007/s00216-009-3225-7.
• [4] Zhang Y, Geißen SU, Gal C. Carbamazepine and diclofenac: Removal in wastewater treatment plants and occurrence in water bodies. Chemosphere. 2008;73:1151-1161. DOI: 10.1016/j.chemosphere.2008.07.086
• [5] Janiec W. Kompendium farmakologii. Warszawa: Wydawnictwo Lekarskie PZWL; 2005.
• [6] Nikolaou A, Meric S, Fatta D. Occurrence patterns of pharmaceuticals in water and wastewater environments. Anal Bioanal Chem. 2007;(387):1225-1234. DOI: 10.1007/s00216-006-1035-8.
• [7] Monteiro SC, Boxall AB. Occurrence and fate of human pharmaceuticals in the environment. Rev Environ Contam Toxicol. 2010;202:53-154. DOI: 10.1007/978-1-4419-1157-5_2.
• [8] Ziylan A, Ince NH. The occurrence and fate of anti-inflammatory and analgesic pharmaceuticals in sewage and fresh water: Treatability by conventional and non-conventional processes. J Hazardous Materials. 2011;187:24-36. DOI: 10.1016/j.jhazmat.2011.01.057.
• [9] Salgado R, Marques R, Noronha JP, Carvalho G, Oehmen A, Reis MAM. Assessing the removal of pharmaceuticals and personal care products in a full-scale activated sludge plant. Environ Sci Pollut Res. 2012;19:1818-1827. DOI: 10.1007/s11356-011-0693-z.
• [10] Klavarioti M, Mantzavinos D, Kassinos D. Removal of residual pharmaceuticals from aqueous systems by advanced oxidation processes. Environ Intern. 2009;35:402-417. DOI: 10.1016/j.envint.2008.07.009.
• [11] Calza P, Medana C, Padovano E, Giancotti V, Minero C. Fate of selected pharmaceuticals in river waters. Environ Sci Pollut Res. 2013;20:2262-2270. DOI: 10.1007/s11356-012-1097-4.
• [12] Tyler CR, Filby AL. Feminized fish, environmental estrogens, and wastewater effluents in English rivers. Emerging Topics in Ecotoxicology. 2011;3:383-412. DOI: 10.1007/978-0-387-89432-4_13.
• [13] Rosal R, Rodea-Palomares I, Boltes K, Fernández-Piñas F, Leganés F. Ecotoxicity assessment of lipid regulators in water and biologically treated wastewater using three aquaticorganisms. Environ Sci Pollut Res. 2010;17:135-144. DOI: 10.1007/s11356-009-0137-1.
• [14] Kasprzyk-Hordern B, Dinsdale RM, Guwy AJ. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. Water Research. 2009;43:363-380. DOI: 10.1016/j.watres.2008.10.047.
• [15] Fent K. Effects of pharmaceuticals on aquatic organisms. Pharmaceuticals in Environment. 2008:175-203.
• [16] Pedrouzo M, Borrull F, Pocurull E, Marcé RM. Presence of pharmaceuticals and hormones in waters from sewage treatment plants. Water Air Soil Pollut. 2011;217:267-281. DOI: 10.1007/s11270-010-0585-8.
• [17] Vulliet E, Cren-Olive C, Grenier-Loustalot MF. Occurrence of pharmaceuticals and hormones in drinking water treated from surface waters. Environ Chem Lett. 2011;9:103-114. DOI: 10.1007/s10311-009-0253-7.
• [18] Szymonik A, Lach J. Pharmaceuticals - potential threats to water environment. Engineering and Protection of Environment.2012;15:249-264.
• [19] Backhaus T, Sumpter J, Blanck H. On the ecotoxicology of pharmaceutical mixtures. Pharmaceuticals in Environment. 2008:257-276.
• [20] He X, Wang Z, Nie X, Yang Y, Pan D, Leung AOW, Cheng Z, Yang Y. Residues of fluoroquinolones in marine aquaculture environment of the Pearl River Delta, South China. Environ Geochem Health. 2012;34:323-335. DOI: 10.1007/s10653-011-9420-4.
• [21] Valcárcel Y, González Alonso S, Rodríguez-Gil JL, Romo Maroto R. Analysis of the presence of cardiovascular and analgesic/anti-inflammatory/antipyretic pharmaceutical in river- and drinking-water of the Madrid Region in Spain. Chemosphere. 2011;82:1062-1071. DOI: 10.1016/j.chemosphere.2010.10.041.
• [22] Daneshvar A, Svanfelt J, Kronberg L, Weyhenmeyer GA. Winter accumulation of acidic pharmaceuticals in a Swedish River. Environ Sci Pollut Res. 2010;17:908-916. DOI: 10.1007/s11356-009-0261-y.
• [23] Kasprzyk-Hordern B, Dąbrowska A, Vieno N, Kronberg L, Nawrocki J. Occurrence of acidic pharmaceuticals in the Warta River in Poland. 2007;52:289-303.
• [24] Zhou LJ, Ying GG, Zhao JL, Yang JF, Wang L. Trends in the occurrence of human and veterinary antibiotics in the sediments of the Yellow River, Hai River and Liao River in northern China. 2011;159:1877-1885. DOI: 10.1016/j.envpol.2011.03.034.
• [25] Tamtam F, Mercier F, Le Bot B, Eurin J, Dinh QT. Occurrence and fate of antibiotics in the Seine River in various hydrological conditions. Sci Total Environ. 2008;393:84-95. DOI: 10.1016/j.scitotenv.2007.12.009.
• [26] Morteani G, Möller P, Fuganti A, Paces T. Input and fate of anthropogenic estrogens and gadolinium in surface water and sewage plants in the hydrological basin of Prague (Czech Republic). Environmental Geochemistry and Health. 2006;28:257-264. DOI: 10.1007/s10653-006-9040-6.
• [27] Wang L, Ying GG, Zhao JL, Yang XB, Chen F. Occurrence and risk assessment of acidic pharmaceuticals in the Yellow River, Hai River and Liao River of north China. Science of the Total Environment. 2010;408:3139-3147. DOI: 10.1016/j.scitotenv.2010.04.047.
• [28] Zheng Q, Zhang R, Wang Y, Pan X. Occurrence and distribution of antibiotics in the Beibu Gulf, China: Impacts of river discharge and aquaculture activities. Marine Environmental Research. 2012;78:26-33. DOI: 10.1016/j.marenvres.2012.03.007.
• [29] Stasinakis AS, Mermigka S, Samaras VG, Farmaki E. Occurrence of endocrine disrupters and selected pharmaceuticals in Aisonas River (Greece) and environmental risk assessment using hazard indexes. Environ Sci Pollut Res. 2012;19:1574-1583. DOI: 10.1007/s11356-011-0661-7.
• [30] Helenkar A, Sebők A, Zaray G, Molnar-Perl I. The role of the acquisition methods in the analysis of the non-steroidal anti-inflammatory drugs in Danube River by gas chromatography - mass spectrometry. Talanta. 2010;82:600-607. DOI: 10.1016/j.talanta.2010.05.014.
• [31] Vystavna Y, Huneau F, Grynenko V, Vergeles Y. Pharmaceuticals in rivers of two regions with contrasted socio-economic conditions: occurrence, accumulation, and comparison for Ukraine and France. Water Air Soil Pollut. 2012;223:2111-2124. DOI: 10.1007/s11270-011-1008-1.
• [32] Kosjek T, Heath E, Krbavčič A. Determination of non-steroidal anti-inflammatory drug (NSAIDs) residues in water samples. Environment Intern. 2005;31:679-685. DOI: 10.1016/j.envint.2004.12.001.
• [33] Shala L, Foster GD. Surface water concentrations and loading budgets of pharmaceuticals and other domestic-use chemicals in an urban watershed (Washington, DC, USA). Arch Environ Contam Toxicol. 2010;58:551-561. DOI: 10.1007/s00244-009-9463-z.
• [34] Baranowska I, Kowalski B. A rapid UHPLC method for the simultaneous determination of drugs from different therapeutic groups in surface water and wastewater. Bull Environ Contam Toxicol. 2012;89:8-14. DOI: 10.1007/s00128-012-0634-7.
• [35] Zgoła-Grześkowiak A. Application of DLLME to isolation and concentration of non-steroidal anti-inflammatory drugs in environmental water samples. Chromatographia. 2010;72:671-678. DOI: 10.1365/s10337-010-1702-y0009-5893/10/10.
• [36] Zhou XF, Dai MC, Zhang YL, Surampalli RY. A preliminary study on the occurrence and behavior of carbamazepine (CBZ) in aquatic environment of Yangtze River Delta, China. Environ Monit Assess. 2011;173:45-53. DOI: 10.1007/s10661-010-1369-8.
• [37] Moldovan Z, Chira R, Alder AC. Environmental exposure of pharmaceuticals and musk fragrances in the Somes River before and after upgrading the municipal wastewater treatment plant Cluj-Napoca, Romania. Environ Sci Pollut Res. 2009;16:46-54. DOI: 10.1007/s11356-008-0047-7.
• [38] Madureira TV, Barreiro JC, Rocha MJ, Rocha E. Spatiotemporal distribution of pharmaceuticals in the Douro River estuary (Portugal). Sci Total Environ. 2010;408:5513-5520. DOI: 10.1016/j.scitotenv.2010.07.069.
• [39] COM 875 report from Commission of European Parliament and the Council on the out come of the review of Annex of Directive 2000/60/EC of the European Parliament and of the Council on priority substances in the field of water policy Brussels 31.01.2012; 2011.